Oramed Pharmaceuticals Inc.
ORMP
$3.65
$0.010.28%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -49.60% | -11.30% | -5.35% | -35.88% | -26.02% |
| Total Receivables | 116.35% | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 198.08% | 77.54% | 116.88% | -10.88% | 24.55% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -48.17% | -6.95% | -4.66% | -35.39% | -25.76% |
|
|
|||||
| Total Current Assets | -48.17% | -6.95% | -4.66% | -35.39% | -25.76% |
| Net Property, Plant & Equipment | 22.90% | 20.14% | 18.85% | 14.73% | -29.01% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -91.47% | 1,661.76% | 3,293.75% | 14,966.67% | 15,233.33% |
| Total Assets | 82.22% | 48.68% | 33.57% | -12.23% | -27.55% |
|
|
|||||
| Total Accounts Payable | -5.50% | -43.85% | -88.79% | -79.47% | -59.83% |
| Total Accrued Expenses | 85.50% | 111.65% | 2,240.00% | -- | 101,300.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 48.07% | 31.94% | 11.52% | 5.60% | -28.74% |
| Total Finance Division Other Current Liabilities | 109.42% | 375.47% | -- | -- | -- |
| Total Other Current Liabilities | 109.42% | 375.47% | -- | -- | -- |
| Total Current Liabilities | 92.33% | 235.73% | 16.04% | -1.07% | -83.63% |
|
|
|||||
| Total Current Liabilities | 92.33% | 235.73% | 16.04% | -1.07% | -83.63% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 310.83% | 246.15% | 216.67% | 174.58% | -55.88% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 859.91% | 181.03% | 179.39% | -8.29% | -50.45% |
| Total Liabilities | 299.88% | 213.36% | 90.01% | 0.40% | -79.84% |
|
|
|||||
| Common Stock & APIC | -0.51% | 0.09% | 0.93% | 0.50% | 0.75% |
| Retained Earnings | 53.80% | 30.11% | 26.35% | -16.46% | -18.10% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 69.22% | 36.56% | 29.94% | -12.73% | -15.50% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 69.22% | 36.56% | 29.94% | -12.73% | -15.50% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -3.59% | -3.84% | 0.00% |
| Total Equity | 70.33% | 37.43% | 30.10% | -12.81% | -15.58% |
|
|
|||||